Ls Investment Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Ls Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$12.95 - $15.41 $196,244 - $233,523	-15,154 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $12,905 - $19,144	-895 Reduced 5.58%	15,154 $221,000
Q4 2020 Feb 10, 2021	BUY	$16.56 - $18.94 $265,771 - $303,968	16,049 New	16,049 $279,000
Q3 2020 Nov 12, 2020	SELL	$17.41 - $19.89 $39,955 - $45,647	-2,295 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$14.43 - $19.16 $33,116 - $43,972	2,295 New	2,295 $41,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $99.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.